Pharmaceutical Excipients Market

Industry Outlook

The pharmaceutical excipients market is expected to reach US$ 11,938.1 million by 2026 from US$ 6,615.7 million in 2017, projecting steady growth at a compound annual growth rate (CAGR) of 6.87% during the forecast period from 2018 to 2026. The World Health Organization (WHO) 2013 initiative states that there is a need for optimal research in healthcare in order to provide universal healthcare facilities to the public. The pharmaceutical and biotechnology industries are working diligently to meet this aspiration. In the current scenario, a trend is noticed in the pharmaceutical industry wherein polymers obtained from natural resources are being replaced by synthetic polymers to achieve the desired drug release profile. Acrylic polymers are widely utilized owing to their increasing application in novel drug delivery systems and their easy manufacturing process.

Another important trend noticed in pharmaceutical drug manufacturing is the increasing preference for binders and coating materials, e.g., BenecelTM, Prosolv®, Soluplus®, etc., due to their easy availability as raw materials and ability to alter the drug pharmacokinetic profile either as a fast-releasing or controlled-release API. Because they are home to key players with developed healthcare infrastructure, North America and Europe currently dominate the pharmaceutical excipients market. Asia Pacific will be the fastest-growing regional segment owing to the rising prevalence of chronic diseases requiring immediate medical attention, proactive government policies majorly focusing on the expansion of the pharmaceutical and biotechnology sectors, and tapping potential markets in far-flung, remote areas with unmet medical needs.

Market Synopsis

Polymers will continue to register their significant growth in the pharmaceutical excipients market.

Polymers are currently dominating the products segment in terms of market revenue and are determined to be the fastest-growing segment during the forecast period from 2018 to 2026. The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) is working in synchronization with the International Conference on Harmonization (ICH) to meet the cGMP guidelines mandated for drug formulation. In the last decade, numerous adverse events related to drug formulations were registered at the global pharmacovigilance monitoring center in Uppsala, Sweden. Polymers currently constitute over 30% of the pharmaceutical excipients market due to their increasing importance in determining the safety and efficacy of the drug formulation. They are currently being produced on a large scale by manufacturers such as Ashland, Inc., Lubrizol Corporation, and FMC Corporation. Polymers are gaining huge popularity owing to the ease of production from natural resources and their tremendous application in novel drug delivery systems, co-processing of excipients, and nanotechnology (DaunoXome®).

During the forecast period, the binder segment will have the highest double-digit CAGR.

Pharmaceutical excipients are used in drug formulation owing to their varied functions, such as diluents and fillers, binders, solvents, coatings, flavoring agents, disintegrants, colorants, lubricants and glidants, and preservatives. Currently, pharmaceutical companies such as BASF SE and Dow Chemical Company are driven by multifaceted demands. The rising demand for pharmaceutical products has resulted in the growth of API production and excipient consumption. Within the pharmaceutical industries, the latest trend observed is reduced R&D activity for novel excipients. Declining price pressure and stringent regulation have forced drug manufacturers to develop excipients such as binders, coating agents, and diluents to create value-added products at low cost without compromising quality. The most recent example is the growing demand for extended-release drug formulations, which are created through the proper use of excipients such as binders and coating agents.

Proactive government policies in Asia-Pacific will set the stage for swift growth during the forecast period.

Major pharmaceutical excipients manufacturers such as BASF SE and Roquette Group are located in Western Europe. Moreover, Europe has been a pioneer in the development of APIs and pharmaceutical excipients for almost a century. The Dow Chemical Company, FMC Corporation, and Lubrizol Corporation are situated in the United States and majorly contribute to the market’s growth in North America. Rising patient pools and proactive government policies actively engaged in the expansion of the pharmaceutical manufacturing industry drive growth in the Asia Pacific pharmaceutical excipients market. In addition, the emergence of local players and government initiatives such as Make in India and China’s 13th annual policy plan is responsible for the growth of the pharmaceutical excipients market in the Asia Pacific. Key vendors are establishing manufacturing subsidiaries to overcome the revenue loss during the shipment of pharmaceutical excipients. Moreover, factors such as the rising prevalence of chronic diseases and the availability of cheap labor and raw materials serve as potential indices for the growth of the pharmaceutical excipient market in Latin America and the Middle East and Africa region. In the Indian context, the Department of Pharmaceuticals has drafted a new National Pharmaceutical Policy (NPP) that has resulted in the banishment of loan licensing to third parties for manufacturing pharmaceutical products. The intentions behind the policy were to cap trade margins, reduce unfair practices, and boost domestic production.

Periods of History and Forecast

2016 : Historic year.

2017: Base Year

2018–2026: Forecast Period

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments is calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The pharmaceutical excipients market report furnishes quantitative analysis along with its latest market trends. The market is segmented by function, product, and geography.

By Product Segment (2016-2026; US Dollar Millions)

• Polymers

• • Ethyl Cellulose
  • Methyl Cellulose
  • Cellulose Hydroxypropyl Methyl
  • Povidone
  • Crosscarmellose Sodium
  • Pregelatinized Starch
  • Glycolate of Sodium Starch
  • Polyethylene Glycols
  • Acrylic Polymers
• Minerals
  • Calcium Phosphate
  • Calcium Carbonate
  • Clay
  • Silicon Dioxide
  • Titanium Dioxide
  • Other ingredients include magnesium oxide, clay, kaolinite, and phyllosilicates.
• Alcohols
  • Glycerin
  • Propylene Glycol
  • Sorbitol
  • Mannitol
  • Others (benzyl alcohol, menthol, polyvinyl alcohol)
• Sugars
  • Lactose
  • Sucrose
  • Others (maltodextrin, cyclodextrin, dextrose, saccharin)
• Petrochemicals
  • Petrolatum
  • Mineral Waxes
  • Mineral Oils
  • Others (Paraben, Paraffin)
• Oleochemicals
  • Fatty Acids
  • Mineral Stearates
  • Others (quaternary ammonium salts, triacylglycerols)
• Proteins
• Other ingredients (Tweens, Spans, Carbomers, and Disodium Edetate)

(2016-2026; US$ Mn) by function segment

• Fillers and diluents
• Binders
• Solvents
• Coatings
• Flavoring Agents
• Disintegrants
• Colorants
• Lubricants and glidants
• Preservatives

Geography Segment (2016-2026; millions of dollars)

• North America

• • United States
  • Canada
• Europe
  • Germany
  • United Kingdom
  • Rest of Europe
• Asia-Pacific (APAC)
  • Japan
  • China
  • Rest of APAC
• Latin America (LATAM)
  • Brazil
  • Mexico
  • rest of Latin America
• Middle East and Africa (MEA)
  • GCC
  • Rest of the Middle East and Africa

The market assessment is an important tool that furnishes us with the latest trends prevalent in the pharmaceutical excipients market with the help of the compound annual growth rate and market size. Competitive analysis helps in mapping the key vendors engaged in the manufacturing of pharmaceutical excipients, with a brief elucidation of the existing competition among them. The product portfolio covers the entire range of excipients utilized for drug formulation and development. Recent news coverage gives valuable insights regarding the latest merger and acquisition and its impact on the pharmaceutical excipients market. The major players spearheading the pharmaceutical excipients market are Archer Daniels Midland Company, Ashland, Inc., Associated British Foods Plc., Ashland, Inc., BASF SE, Croda International Plc., The Dow Chemical Company, Evonik Industries AG, FMC Corporation, Lubrizol Corporation, and Roquette Group.

Key questions are answered in this report.

• What are the latest trends in the pharmaceutical excipients market and the most valuable opportunities for the key players?
• Who is the leading player in the global pharmaceutical excipients market?
• Which region leads and grows the most in the global pharmaceutical excipients market?
• Which are the largest and fastest-growing excipients in the global pharmaceutical excipients market?
• Where is the maximum production happening? Which region is importing the most pharmaceutical excipients?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Phase III-Expert Panel Review
1.3.4. Assumptions

Chapter 2. Executive Summary
2.1. Global Pharmaceutical Excipients Market, by Product, 2017 (US$ Mn)
2.2. Global Pharmaceutical Excipients Market, by Function, 2017 (US$ Mn)
2.3. Global Pharmaceutical Excipients Market, by Geography, 2017 (US$ Mn)

Chapter 3. Pharmaceutical Excipients Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, 2017
3.6. Competitive Landscape of Key Players in Pharmaceutical Excipients Market

Chapter 4. Global Pharmaceutical Excipients Market, by Product, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Polymers
4.2.1. Ethyl Cellulose
4.2.2. Methyl Cellulose
4.2.3. Hydroxy Propyl Methyl Cellulose
4.2.4. Povidone
4.2.5. Crosscarmellose Sodium
4.2.6. Pregelatinized Starch
4.2.7. Sodium Starch Glycolate
4.2.8. Polyethylene Glycols
4.2.9. Acrylic Polymers
4.3. Minerals
4.3.1. Calcium Phosphate
4.3.2. Calcium Carbonate
4.3.3. Clay
4.3.4. Silicon Dioxide
4.3.5. Titanium Dioxide
4.3.6. Others (Magnesium Oxide, Clay Kaolinite, Phyllosilicates)
4.4. Alcohols
4.4.1. Glycerin
4.4.2. Propylene Glycol
4.4.3. Sorbitol
4.4.4. Mannitol
4.4.5. Others (Benzyl Alcohol, Menthol, Polyvinyl Alcohol)
4.5. Sugars
4.5.1. Lactose
4.5.2. Sucrose
4.5.3. Others (Maltodextrin, Cyclodextrin, Dextrose, Saccharin)
4.6. Petrochemicals
4.6.1. Petrolatum
4.6.2. Mineral Waxes
4.6.3. Mineral Oils
4.6.4. Others (Paraben, Paraffin)
4.7. Oleochemicals
4.7.1. Fatty Acids
4.7.2. Mineral Stearates
4.7.3. Others (Quaternary Ammonium Salts, Triacylglycerols)
4.8. Proteins
4.9. Others (Tweens, Spans, Carbomers, Disodium Edetate)

Chapter 5. Global Pharmaceutical Excipients Market, by Function, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. Fillers and Diluents
5.3. Binders
5.4. Solvents
5.5. Coatings
5.6. Flavoring Agents
5.7. Disintegrants
5.8. Colorants
5.9. Lubricants and Glidants
5.10. Preservatives

Chapter 6. Global Pharmaceutical Excipients Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. North America Pharmaceutical Excipients Market Analysis, 2016 – 2026 (US$ Mn)
6.2.1. North America Pharmaceutical Excipients Market, by Country, 2016 – 2026 (US$ Mn)
6.2.1.1. U.S.
6.2.1.2. Canada
6.3. Europe Pharmaceutical Excipients Market Analysis, 2016 – 2026 (US$ Mn)
6.3.1. Europe Pharmaceutical Excipients Market, by Country, 2016 – 2026 (US$ Mn)
6.3.1.1. U.K.
6.3.1.2. Germany
6.3.1.3. Rest of Europe
6.4. Asia Pacific Pharmaceutical Excipients Market Analysis, 2016 – 2026 (US$ Mn)
6.4.1. Asia Pacific Pharmaceutical Excipients Market, by Country, 2016 – 2026 (US$ Mn)
6.4.1.1. China
6.4.1.2. Japan
6.4.1.3. Rest of APAC
6.5. Latin America Pharmaceutical Excipients Market Analysis, 2016 – 2026 (US$ Mn)
6.5.1. Latin America Pharmaceutical Excipients Market, by Country, 2016 – 2026 (US$ Mn)
6.5.1.1. Brazil
6.5.1.2. Mexico
6.5.1.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Pharmaceutical Excipients Market Analysis, 2016 – 2026 (US$ Mn)
6.6.1. MEA Pharmaceutical Excipients Market, by Region, 2016 – 2026 (US$ Mn)
6.6.1.1. GCC
6.6.1.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Archer Daniels Midland Company
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Associated British Foods Plc.
7.3. Ashland, Inc.
7.4. BASF SE
7.5. Croda International Plc
7.6. The Dow Chemical Company
7.7. Evonik Industries AG
7.8. FMC Corporation
7.9. Lubrizol Corporation
7.10. Roquette Group

List of Figures

FIG. 1 Pharmaceutical Excipients: Market Segmentation
FIG. 2 Global Pharmaceutical Excipients Market, by Product, 2017 (US$ Mn)
FIG. 3 Global Pharmaceutical Excipients Market, by Function, 2017 (US$ Mn)
FIG. 4 Global Pharmaceutical Excipients Market, by Geography, 2017 (US$ Mn)
FIG. 5 Attractive Investment Proposition: Global Pharmaceutical Excipients Market, by Geography, 2017
FIG. 6 Market Competition Landscape: Global Pharmaceutical Excipients Market, by Key Players, 2017
FIG. 7 Global Ethyl Cellulose Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 8 Global Methyl Cellulose Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 9 Global HPMC Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 10 Global Povidone Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 11 Global Crosscarmellose Sodium Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 12 Global Pregelatinized Starch Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 13 Global Sodium Starch Glycolate Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 14 Global Polyethylene Glycols Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 15 Global Acrylic Polymers Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 16 Global Calcium Phosphate Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 17 Global Calcium Carbonate Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 18 Global Clay Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 19 Global Silicon Dioxide Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 20 Global Titanium Dioxide Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 21 Global Others Minerals Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 22 Global Glycerin Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 23 Global Propylene Glycol Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 24 Global Sorbitol Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 25 Global Mannitol Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 26 Global Other Alcohols Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 27 Global Lactose Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 28 Global Sucrose Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 29 Global Other Sugars Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 30 Global Petrolatum Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 31 Global Mineral Waxes Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 32 Global Mineral Oils Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 33 Global Other Petrochemicals Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 34 Global Fatty Acids Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 35 Global Mineral Stearates Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 36 Global Other Oleochemicals Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 37 Global Proteins Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 38 Global Other Products Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 39 Global Fillers and Diluents Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 40 Global Binders Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 41 Global Solvents Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 42 Global Coatings Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 43 Global Flavoring Agents Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 44 Global Disintegrants Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 45 Global Colorants Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 46 Global Lubricants and Glidants Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 47 Global Preservatives Market for Pharmaceutical Excipients, 2016 – 2026 (US$ Mn)
FIG. 48 U.S. Pharmaceutical Excipients Market, 2016 – 2026 (US$ Mn)
FIG. 49 Canada Pharmaceutical Excipients Market, 2016 – 2026 (US$ Mn)
FIG. 50 U.K. Pharmaceutical Excipients Market, 2016 – 2026 (US$ Mn)
FIG. 51 Germany Pharmaceutical Excipients Market, 2016 – 2026 (US$ Mn)
FIG. 52 Rest of Europe Pharmaceutical Excipients Market, 2016 – 2026 (US$ Mn)
FIG. 53 China Pharmaceutical Excipients Market, 2016 – 2026 (US$ Mn)
FIG. 54 Japan Pharmaceutical Excipients Market, 2016 – 2026 (US$ Mn)
FIG. 55 Rest of Asia Pacific Pharmaceutical Excipients Market, 2016 – 2026 (US$ Mn)
FIG. 56 Brazil Pharmaceutical Excipients Market, 2016 – 2026 (US$ Mn)
FIG. 57 Mexico Pharmaceutical Excipients Market, 2016 – 2026 (US$ Mn)
FIG. 58 Rest of Latin America Pharmaceutical Excipients Market, 2016 – 2026 (US$ Mn)
FIG. 59 GCC Pharmaceutical Excipients Market, 2016 – 2026 (US$ Mn)
FIG. 60 Rest of Middle East and Africa Pharmaceutical Excipients Market, 2016 – 2026 (US$ Mn)

List of Tables

TABLE 1 Global Pharmaceutical Excipients Market Portraiture
TABLE 2 Global Pharmaceutical Excipients Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 3 Global Polymers Market for Pharmaceutical Excipients, by Product, 2016 – 2026 (US$ Mn)
TABLE 4 Global Minerals Market for Pharmaceutical Excipients, by Product, 2016 – 2026 (US$ Mn)
TABLE 5 Global Alcohols Market for Pharmaceutical Excipients, by Product, 2016 – 2026 (US$ Mn)
TABLE 6 Global Sugars Market for Pharmaceutical Excipients, by Product, 2016 – 2026 (US$ Mn)
TABLE 7 Global Petrochemicals Market for Pharmaceutical Excipients, by Product, 2016 – 2026 (US$ Mn)
TABLE 8 Global Oleochemicals Market for Pharmaceutical Excipients, by Product, 2016 – 2026 (US$ Mn)
TABLE 9 Global Pharmaceutical Excipients Market, by Function, 2016 – 2026 (US$ Mn)
TABLE 10 Global Pharmaceutical Excipients Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 11 North America Pharmaceutical Excipients Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 12 Europe Pharmaceutical Excipients Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific Pharmaceutical Excipients Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 14 Latin America Pharmaceutical Excipients Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 15 Middle East and Africa Pharmaceutical Excipients Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 16 Archer Daniels Midland Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 17 Associated British Foods Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 18 Ashland, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 19 BASF SE: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 20 Croda International Plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 The Dow Chemical Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Evonik Industries AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 FMC Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Lubrizol Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Roquette Group: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)